Skip to main content

Advertisement

Table 5 Cost effectiveness and cost utility ratios (in EURO) (main analysis)*

From: Surgery is more cost-effective than splinting for carpal tunnel syndrome in the Netherlands: results of an economic evaluation alongside a randomized controlled trial

Costs Surgery (n = 73)** Splint (n = 82)** Ratio
  Costs Effects Costs Effects  
# Nights waking up due to complaints (0–7) 2,215 3.6 2,244 2.9 -40
Severity of the main complaint (0–10) 2,215 6.4 2,244 5.1 -21
Paraesthesia during the day (0–10) 2,215 5.5 2,244 4.0 -19
Paraesthesia at night (0–10) 2,215 5.2 2,244 4.5 -40
Utility (EuroQol; 0–1)*** 2,126 0.85 2,111 0.81 353
  1. EURO 1 = US $0.90; *Presented are the mean (standard deviation) improvements from baseline; ** Patients with missing data on either outcome measures or costs are excluded; *** Number of patients for utility in surgery (n = 79) and splint (n = 88).